Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (261-270 of 329) with videos related to

Pageof 33
Sort By:
Clinical Lung Cancer|October 26, 2019
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE TrialJaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, et al.
ERJ Open Research|October 13, 2016
Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national surveyVincent Cottin, Emmanuel Bergot, Arnaud Bourdin, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2025
Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS"Elisa Gobbini, Alexandra Langlais, Pascale Missy, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France projectMichèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.
Respiration; International Review of Thoracic Diseases|September 13, 2021
Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD CohortVincent Cottin, Sonia Gueguen, Stéphane Jouneau, et al.
Neurology|August 10, 2018
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancerMehdi Touat, Thierry Maisonobe, Samuel Knauss, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2025
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDSElisa Gobbini, Alexandra Langlais, Pascale Missy, et al.
The European Respiratory Journal|March 17, 2018
Cost-effectiveness of <i>KRAS</i>, <i>EGFR</i> and <i>ALK</i> testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm studySandrine Loubière, Alexandre Drezet, Michèle Beau-Faller, et al.
Frontiers in Immunology|August 10, 2019
Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 PatientsCindy Marques, Julien Carvelli, Lucie Biard, et al.
Pageof 33

Showing results (261-270 of 329) with videos related to

Sort By:
Pageof 33
Clinical Lung Cancer|October 26, 2019
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE TrialJaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, et al.
ERJ Open Research|October 13, 2016
Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national surveyVincent Cottin, Emmanuel Bergot, Arnaud Bourdin, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2025
Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS"Elisa Gobbini, Alexandra Langlais, Pascale Missy, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France projectMichèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.
Respiration; International Review of Thoracic Diseases|September 13, 2021
Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD CohortVincent Cottin, Sonia Gueguen, Stéphane Jouneau, et al.
Neurology|August 10, 2018
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancerMehdi Touat, Thierry Maisonobe, Samuel Knauss, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2025
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDSElisa Gobbini, Alexandra Langlais, Pascale Missy, et al.
The European Respiratory Journal|March 17, 2018
Cost-effectiveness of <i>KRAS</i>, <i>EGFR</i> and <i>ALK</i> testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm studySandrine Loubière, Alexandre Drezet, Michèle Beau-Faller, et al.
Frontiers in Immunology|August 10, 2019
Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 PatientsCindy Marques, Julien Carvelli, Lucie Biard, et al.
Pageof 33